Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04549935 · ClinicalTrials.gov registry record · Phase 4
The PRIME Study: A Randomized, Controlled, Prospective Study
A Phase 4 study of Patient Preference and Patient Outcomes, sponsored by Vance Thompson Vision - MT.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04549935 is a Phase 4 study of Patient Preference and Patient Outcomes that is actively recruiting participants, run by Vance Thompson Vision - MT. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04549935, a Phase 4 study of Patient Preference and Patient Outcomes, is actively recruiting participants, sponsored by Vance Thompson Vision - MT.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To investigate the outcomes of patients undergoing bilateral RLE surgery with treatment of dexamethasone intracanilicular insert compared to topical standard care steroid. Desiged to look at patient preference comparing the insert to drops and will also look at patient outcomes including inflammatin and risk of cystoid macular edema post-operatively.
Conditions Studied
Interventions
- DRUG Dextenza
- DRUG Topical Prednisolone
Study Locations (1)
Montana
- Briana Parker - Bozeman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2021-08-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04549935
The ClinicalTrials.gov registry entry for NCT04549935 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision - MT, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Patient Preference appearing as the primary indexed condition, and to 2 interventions - of which Dextenza is the first listed.
NCT04549935 reports 1 study location spanning 1 distinct geographic area - top geographies include Montana.
Frequently Asked Questions
What is clinical trial NCT04549935 about?
NCT04549935 is a clinical study titled "The PRIME Study: A Randomized, Controlled, Prospective Study". To investigate the outcomes of patients undergoing bilateral RLE surgery with treatment of dexamethasone intracanilicular insert compared to topical standard care steroid. Desiged to look at patient preference comparing the insert to drops and will also look at patient outcomes including inflammatin...
What is the current status of trial NCT04549935?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2020-09-14. Estimated completion is 2021-08-27.
What conditions does trial NCT04549935 study?
This clinical trial studies the following conditions: Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema.
What interventions are being tested in trial NCT04549935?
The interventions under investigation include: Dextenza (DRUG), Topical Prednisolone (DRUG).
Who is sponsoring clinical trial NCT04549935?
This trial is sponsored by Vance Thompson Vision - MT, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04549935 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Preference
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.